Divestment paves way for GSK/Novartis deal

26 November 2014 - Deborah Wilkes

Archived

The US Federal Trade Commission (FTC) has approved the formation of the consumer healthcare joint venture between GlaxoSmithKline and Novartis following a product divestment.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: